Literature DB >> 20032218

Oral administration of beta-1,3/1,6-glucan to dogs temporally changes total and antigen-specific IgA and IgM.

E Stuyven1, F Verdonck, I Van Hoek, S Daminet, L Duchateau, J P Remon, B M Goddeeris, E Cox.   

Abstract

The effect of oral administration of beta-1,3/1,6-glucans from Saccharomyces cerevisiae on humoral immunity in domestic dogs is not known. In this study, 15 beagle dogs were orally given MacroGard tablets, which contain 150 mg of this beta-glucan, daily for 4 weeks. At the end of this period, the total serum immunoglobulin A (IgA) level decreased significantly in the group treated with the glucan compared to that in the control group as well as compared to the concentrations before supplementation. In contrast, the total serum IgM level rose significantly, whereas no effect on the IgG level occurred. Similar changes were seen in Bordetella-specific IgA and IgM titers following vaccination during the supplementation period. The IgA concentration also became significantly lower in the saliva and tears of the glucan group than in the placebo group. The effects disappeared 1 week after the cessation of the supplementation. In conclusion, the results showed a temporary change in the isotype profile during glucan supplementation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032218      PMCID: PMC2815531          DOI: 10.1128/CVI.00344-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  40 in total

1.  Immunopotentiation of intraepithelial lymphocytes in the intestine by oral administrations of beta-glucan.

Authors:  Chika Tsukada; Hisashi Yokoyama; Chikako Miyaji; Yuiko Ishimoto; Hiroki Kawamura; Toru Abo
Journal:  Cell Immunol       Date:  2003-01       Impact factor: 4.868

2.  Oral administration of SSG, a beta-glucan obtained from Sclerotinia sclerotiorum, affects the function of Peyer's patch cells.

Authors:  K Hashimoto; I Suzuki; T Yadomae
Journal:  Int J Immunopharmacol       Date:  1991

Review 3.  Natural and modified (1-->3)-beta-D-glucans in health promotion and disease alleviation.

Authors:  Djordje B Zeković; Stefan Kwiatkowski; Miroslav M Vrvić; Dragica Jakovljević; Colm A Moran
Journal:  Crit Rev Biotechnol       Date:  2005 Oct-Dec       Impact factor: 8.429

4.  Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers.

Authors:  G Lehne; B Haneberg; P Gaustad; P W Johansen; H Preus; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

5.  Short- and long-term effects of a dietary yeast beta-glucan (Macrogard) and alginic acid (Ergosan) preparation on immune response in sea bass (Dicentrarchus labrax).

Authors:  M Bagni; N Romano; M G Finoia; L Abelli; G Scapigliati; P G Tiscar; M Sarti; G Marino
Journal:  Fish Shellfish Immunol       Date:  2005-04       Impact factor: 4.581

Review 6.  Fungal beta-glucans and mammalian immunity.

Authors:  Gordon D Brown; Siamon Gordon
Journal:  Immunity       Date:  2003-09       Impact factor: 31.745

7.  Purification of soluble beta-glucan with immune-enhancing activity from the cell wall of yeast.

Authors:  J N Lee; D Y Lee; I H Ji; G E Kim; H N Kim; J Sohn; S Kim; C W Kim
Journal:  Biosci Biotechnol Biochem       Date:  2001-04       Impact factor: 2.043

8.  Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo.

Authors:  A B Onderdonk; R L Cisneros; P Hinkson; G Ostroff
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Extensive interbreed, but minimal intrabreed, variation of DLA class II alleles and haplotypes in dogs.

Authors:  Lorna J Kennedy; A Barnes; G M Happ; R J Quinnell; D Bennett; J M Angles; M J Day; N Carmichael; J F Innes; D Isherwood; S D Carter; W Thomson; W E R Ollier
Journal:  Tissue Antigens       Date:  2002-03

10.  Oral beta-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice.

Authors:  Jarek Baran; Daniel J Allendorf; Feng Hong; Gordon D Ross
Journal:  Folia Histochem Cytobiol       Date:  2007       Impact factor: 1.698

View more
  5 in total

1.  Immune modulation by non-digestible and non-absorbable beta-1,3/1,6-glucan.

Authors:  Jan Raa
Journal:  Microb Ecol Health Dis       Date:  2015-05-29

2.  GUT in FOCUS Symposium NOBEL FORUM, Karolinska Institutet, February 2nd 2015.

Authors: 
Journal:  Microb Ecol Health Dis       Date:  2015-05-29

3.  Chitosan microparticles loaded with yeast-derived PCV2 virus-like particles elicit antigen-specific cellular immune response in mice after oral administration.

Authors:  Sergio A Bucarey; Myriam Pujol; Joaquín Poblete; Ignacio Nuñez; Cecilia V Tapia; Andrónico Neira-Carrillo; Jonatán Martinez; Oliver Bassa
Journal:  Virol J       Date:  2014-08-20       Impact factor: 4.099

4.  Oat beta-glucan as a dietary supplement for dogs.

Authors:  Lívia Geraldi Ferreira; Mariangela Endrighi; Karen Guttenkunst Lisenko; Maiara Rodrigues Duarte de Oliveira; Mateus Resende Damasceno; Jelieny Aparecida Claudino; Pamella Godinho Gutierres; Ana Paula Peconick; Flávia Maria de Oliveira Borges Saad; Márcio Gilberto Zangeronimo
Journal:  PLoS One       Date:  2018-07-31       Impact factor: 3.240

5.  Recurrent bacterial pneumonia in Irish Wolfhounds: Clinical findings and etiological studies.

Authors:  Sanna J Viitanen; Anu K Lappalainen; Ninna M Koho; Tiina Pessa-Morikawa; Lorenzo Ressel; Minna M Rajamäki
Journal:  J Vet Intern Med       Date:  2019-01-21       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.